A Multicentre, Randomised, Open-label, Controlled, 12-month Follow-up Study to Assess Impact on Renal Function of an Immunosuppression Regimen Based on Tacrolimus Minimisation in Association With Everolimus in de Novo Liver Transplant Recipients.
Clinical trial NCT02040584 · COMPLETED
Trial details
- NCT number
- NCT02040584
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-20
- Primary completion
- 2016-02-10
- Enrollment
- 217
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.